Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeCEL-SCI Corporation

CEL-SCI Corporation

CEL-SCI Initiates Development of Immunotherapy to Treat COVID-19 Coronavirus Infection Using its Patented LEAPS Peptide Technology.

The LEAPS peptides will utilize conserved regions of coronavirus proteins to stimulate protective cell-mediated T cell responses and reduce viral load. The LEAPS peptide technology can be used to construct immunotherapeutic peptides that exhibit both antiviral and anti-inflammatory properties. Consequently, these products not only target the virus infection against which they are directed, but also elicit the appropriate protective response(s) against it.

By using this website you agree to accept Medical Device News Magazine Privacy Policy